Polyphor is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer.
Business Model:
Revenue: $10.3k
Employees: 51-200
Address: Hegenheimermattweg 125
City: Allschwil
State: basel-country
Zip: CH-4123
Country: CH
Polyphor is a biopharmaceutical company that develops and commercializes novel therapies for the treatment of cancer.
Contact Phone:
Contact Email:
Listed Exchange:
SIX Swiss Exchange
IPO Date:
5/15/2018
Ticker Symbol:
POLN
IPO Price:
$37.94615440689661/share
Amount Raised:
$165M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2017 | Venture Round | $39.8M | 9/2018 | Post-IPO Equity | 1 | $7M |
Repair Impact Fund Repair Impact Fund Repair Impact Fund Repair Impact Fund |
5/2001 | Venture Round | 2 | $9.3M |
Novartis Venture Fund New Medical Technologies Novartis Venture Fund New Medical Technologies |
12/2020 | Grant | 1 | $2.3M |
CARB-X CARB-X |
2/2019 | Grant | 1 | $5.6M |
CARB-X CARB-X CARB-X CARB-X |
10/2020 | Grant | 1 | $18.4M |
CARB-X CARB-X |
11/2020 | Grant | 1 | $3.3M |
Cystic Fibrosis Foundation Cystic Fibrosis Foundation |
8/2000 | Venture Round | $1.8M | 4/2017 | Equity | $9.9M | 10/2020 | Grant | $18.4M |
CARB-X |
5/2018 | IPO | $154.8M |
---|
Announced Date | Name | Price |
---|---|---|
9/2021 | EnBiotix |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|